Site icon news.soban.in

Wockhardt exits its US generics business

As part of the strategic realignment of its US business, the company has filed for voluntary liquidation under Chapter 7 of the US Bankruptcy Code for its US step down subsidiaries, Morton Grove Pharmaceuticals Inc. and Wockhardt USA LLC.

Exit mobile version